diabetes cardiovascular disease

Popular insulin meets target in real-world studyNovo Nordisk’s DEVOTE study reveals interesting findings.
New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.
New drug indication could net more than $1 billionFDA’s approval of a new indication for empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) could net the pharmaceutical manufacturers more than $1 billion.